Chongqing Liyang Pharmaceutical Development Co., Ltd.
Congratulations on the launch of the website for Chongqing Liyang Pharmaceutical Development Co., Ltd.!
Release Time:
2022-05-06 09:15
Source:
Chongqing Liyang Pharmaceutical Development Co., Ltd. was established in 2001 and is a high-tech enterprise specializing in the research and development of pharmaceutical formulations. The company has established robust technical platforms for injectable preparations, oral solid dosage forms, and topical semi-solid formulations, as well as advanced platforms for innovative dosage forms such as oral drug delivery systems and complex formulations like combination products. Our primary business areas include the development of generic high-end formulations, consistency evaluation, and the research and innovation of novel pharmaceutical preparations.
The company adheres to the philosophy of "Empowering You with Our Expertise," delivering high-quality, efficient pharmaceutical research and technical services. We are committed to accelerating our clients' R&D progress, enhancing their success rates in drug development, and supporting enterprises in transforming and upgrading their product portfolios. Ultimately, we aim to provide clinical settings with medications that boast superior quality, efficacy, and safety profiles.
In collaboration with industry partners, the company has successfully obtained domestic New Drug Certificates or Production Approvals for orally disintegrating tablets. Additionally, we have achieved the industrialization of innovative, improved drugs backed by independent intellectual property rights. Ongoing research into complex formulations, such as combination preparations, continues to advance steadily.
The company is currently conducting research on multiple improved new drugs, aiming to collaborate with various sectors to accelerate the transition toward clinical trials and industrialization, ultimately serving human health more effectively.
Related News
Biopharmaceutical Industry: A Powerful Innovation Engine Driving Global Market Competition
The deep integration of artificial intelligence technology has transformed drug development from "searching for a needle in a haystack" to "precise navigation."
Intermediate, a material generated during the active pharmaceutical ingredient (API) manufacturing process that requires further molecular transformation or purification before it can be finalized as an API.
What are the differences between active pharmaceutical ingredients and finished dosage forms?
Active pharmaceutical ingredients (APIs) are the active components of drugs and cannot be used directly for clinical treatment. Pharmaceutical preparations, on the other hand, are drug formulations made by processing APIs with excipients, ready for direct use by patients.
The method of decocting traditional Chinese medicine
First, pour the medicinal herbs into the decoction vessel and add cool water until the herbs are fully submerged. Allow them to soak for about an hour, enabling the traditional Chinese medicine to absorb moisture thoroughly and return to a fresh state. This process ensures that the active ingredients can be released more quickly and efficiently.
What are the common types of liquid formulations?
This is a common type of liquid formulation, referring to a homogeneous system in which the drug is uniformly dispersed in the solvent in molecular or ionic form.
Trends in the Pharmaceutical Industry
Breakthroughs in biotechnology and artificial intelligence are driving advancements in new drug development, paving the way for more innovative therapies and offering patients a wider range of treatment options.
National Service Hotline
